Glenmark unveils COPD treatment Tavulus in Spain Ruchika Sharma11 Oct 2021 11:34 AM ISTTavulus is a long-acting bronchodilator that helps to open the airways and makes it easier for air to get in and out of the lungs.
Chronic cough: An annoyance under appreciated MD Brand Connect7 Oct 2021 3:24 PM ISTPanel Discussion on Chronic Cough, its diagnosis and Management.
COPD patients with pulmonary hypertension have worse prognosis, finds study MD Editorial Team28 Sept 2021 9:00 AM ISTIn a study done by Carmine Dario Vizza and colleagues, it was discovered that patients with pulmonary hypertension (PH) in Chronic Obstructive...
Zydus Healthcare gets CDSCO panel nod for study of Indacaterol, Budesonide inhaler Medical Dialogues Team10 Sept 2021 2:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has shown a green light to Zydus...
People who consume low carbohydrate diet less likely to get COPD: Study Medha Baranwal9 Sept 2021 9:15 AM ISTTehran, Iran: A recent study has found an inverse association between adherence to a low-carbohydrate diet (LCD) and risk of chronic obstructive...
Hotter weather associated with increased COPD exacerbations, finds study Hina Zahid6 Sept 2021 9:00 AM ISTWarmer weather is linked to a worsening of chronic obstructive pulmonary disease (COPD) symptoms, according to research to be presented on Sunday at...
Lupin launches asthma, COPD drug Luforbec in UK Ruchika Sharma24 Aug 2021 5:13 PM ISTLuforbec is first branded generic alternative to Fostair 100/6 g pMDI for treatment of Asthma and COPD.
Self-administered high-flow therapy not of much benefit for COPD and type 1 respiratory failure: Study Dr. Kamal Kant Kohli22 July 2021 10:39 AM ISTDelhi: The available study data did not show any benefit of high-flow therapy (HFT) in patients with advanced chronic obstructive pulmonary disease...
Tissue Doppler may detect LV Dysfunction in COPD patients without pulmonary hypertension Dr. Nandita Mohan19 July 2021 8:45 AM ISTSubclinical LV systolic dysfunction was a frequent finding in a cohort of COPD patients, even in those with normal pulmonary artery pressure, finds...
Inhibition of cell death could be a potential therapeutic strategy in COPD: Study Hina Zahid22 Jun 2021 9:00 AM ISTResults suggest that it is the type of cell death associated with COPD that is important and that the development of new drugs that can interfere or...
Compared to dual therapy, Triple therapy doesn`t improve survival in COPD: Study Dr. Nandita Mohan14 Jun 2021 8:30 AM ISTRecent research reveals that no differences in mortality between LAMA+LABA and triple therapy in patients with moderate-to-very severe COPD and...
Hyperconcentration of lung protein may predict COPD risk: Lancet Hina Zahid5 Jun 2021 9:58 AM ISTMUC5AC is found at elevated levels in smokers who had not yet developed COPD but whose lung function wound up decreasing over the course of the...
